Pfizer share news, announcements and annual reports
NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap
Pfizer Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1966 on BSE, Apr 1999 on NSE
Last close ₹3,638.70down ₹49.10 (1.33%)BSE ₹3,637.90
Share price at the NSE close on 2 Nov 2026. Previous close ₹3,687.80.
2 Nov: open ₹3,687.80, high ₹3,718.20, low ₹3,613.60
52-week range of traded prices to 2 Nov 2026
₹3,589.00Low, 23 Oct 2026₹5,339.00High, 13 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹16,646 Cr327th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.64
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.96
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.06%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 55,74259.3% delivered
Pfizer share news and announcements
658 announcements, routine notices left out, newest first. Page 14 of 14.
Jun 2007
21 Jun · Board meeting
To consider the Unaudited Financial Results of the Company for the 2nd Quarter ended May 31, 2007.
May 2007
4 May · Limited Review Report
Pfizer Ltd. has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended February 28, 2007 and found the same to be in order subject to certain observations. The auditor's observations are : As per the revised recommendation of the Board of Directors, the shareholders in the Annual General Meeting on 22 March 2007 approved the increased rate of dividend of 225% from the earlier proposed rate of 125% . Pursuant to the same the reserves as at 30 November 2006 as reported in the results is overstated by Rs 3402.80 lacs. However this does not have any impact on total capital employed, total income and net profit as at and for the quarter ended 28 February 2007.
Mar 2007
22 Mar · Dividend
Pfizer Ltd. has informed the Exchange on March 22, 2007 that : "At the Annual General Meeting of the Company held today the Shareholders approved the increase in final dividend payable by the Company for the Accounting Year 30th November, 2006 from Rs.12.50 per share (as recommended earlier by the Board) to Rs.22.50 per share."16 Mar · Sale
Pfizer Ltd. has informed the Exchange that "the company has disposed off its Chandigarh property "on as is where is" basis to M/s C.S.J.Infrastructure Pvt.Ltd for a total consideration of Rs.278 Crores. Out of a said consideration, the Company had already received advance of Rs.27.8 Crores, being 10% as initial advance and the same was accounted in the Quarter ending 30th November, 2006. The Chandigarh Plant of the Company stopped operations in November 2003 and all the permanent employees had opted for VRS. The assets comprising of Land & Building, Plant & Machinery, Furniture & Fixtures, Movables, were shown as "Assets held for Disposal" in the Balance Sheet of the Company since then".14 Mar · Board meeting
To consider the Unaudited Financial Results of the Company for the 1st Quarter ended February 28, 2007.
Feb 2007
13 Feb · Meeting
Pfizer Ltd. has informed the Exchange that the Transfer Books (Register of Members) will remain closed from March 13, 2007 to March 22, 2007 (both days inclusive) for the purpose of determining the eligibility of payment of Dividend. The Board of Directors has recommended a Dividend of Rs. 12.50/- per Equity Share (125%) and the same shall be paid after approval of shareholders at the ensuing Annual General Meeting. Subject to the aforesaid, the Dividend Warrants will be dispatched on March 27, 2007. The Company has further informed that the Annual General Meeting of the Company is scheduled to be held on March 22, 2007.
Jan 2007
20 Jan · Dividend
Pfizer Ltd. has informed the Exchange that the Board of Directors of the Company at its Meeting held on January 20, 2007 has recommended a Dividend of Rs. 12.50 (125%) per equity share of Rs.10/- each for the Financial Year ended November 30, 2006.12 Jan · Board meeting
To consider the Audited Statement of Accounts of the Company for the year ended November 30, 2006 and to recommend dividend thereon.